What's in Wanbangde Pharmaceutical Group Co., LTD's pipeline?

Wanbangde Pharmaceutical Group Co., LTD has 3 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Wanbangde Pharmaceutical Group Co., LTD's portfolio?

Top competitors by shared drug class: Chung-Ang University Hosptial, Chung-Ang University College of Medicine, Eisai Co., Ltd., Icure Pharmaceutical Inc., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Merck Sharp & Dohme LLC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/wanbangde-pharmaceutical-group-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Wanbangde Pharmaceutical Group Co., LTD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Wanbangde Pharmaceutical Group Co., LTD pipeline: 1 marketed, 0 filed, 0 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Ginkgo leaf dropping pill	Ginkgo leaf dropping pill	marketed	Herbal extract / Traditional medicine		Neurology / Cognitive disorders

Therapeutic area mix

Neurology · 1
Neurology / Cognitive disorders · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Chung-Ang University Hosptial, Chung-Ang University College of Medicine · 1 shared drug class
Eisai Co., Ltd. · 1 shared drug class
Icure Pharmaceutical Inc. · 1 shared drug class
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
Novartis · 1 shared drug class
Pfizer · 1 shared drug class
Pontificia Universidade Catolica de Sao Paulo · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Wanbangde Pharmaceutical Group Co., LTD:

Cite this brief

Drug Landscape (2026). Wanbangde Pharmaceutical Group Co., LTD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/wanbangde-pharmaceutical-group-co-ltd. Accessed 2026-05-16.